On November 6, Aehr Test rose 8.79% in Pre-Market Trading, trading at $53.5/share, with turnover of $0.8678 million.
The move follows the company’s recently reported first-quarter results that exceeded expectations and its higher full-year revenue outlook, with recent AI chip testing orders continuing to support sentiment.
Reported figures showed adjusted EPS of $0.28 versus the $0.11 consensus estimate, while revenue reached $33.007 million versus expectations of $27.072 million. The company also said backlog stood at $100.9 million as of September 25 and noted additional orders tied to AI chip testing, including a fully configured FOX-XP wafer-level burn-in system scheduled for installation in Taiwan in early next year.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments